IDWeek Research: COVID-19 Timing and Infant CHD Risk in 161,731 Pairs
Timing a COVID-19 infection during specific gestational weeks alters the risk of congenital heart disease in infants, according to research presented at IDWeek. Researchers analyzed 161,731 mother-infant pairs to track how viral exposure during periconception and early pregnancy impacts fetal cardiac development.
- Maternal COVID-19 infection between 3 and 8 weeks of gestation shows a positive association with critical congenital heart disease, ventricular septal defects, and atrial septal defects.
- Infections occurring strictly during the periconception window demonstrate no association with infant congenital heart disease outcomes.
- Maternal vaccination received up to six months before periconception shows no difference in congenital heart disease risk.
Archer Examines COVID-19 Exposure in 161,731 Pregnancies
Helena Archer, PhD, MPH, and her research colleagues built a retrospective cohort study examining singleton pregnancies conceived between January 2020 and December 2024. The study gathered data on maternal COVID-19 diagnoses across three distinct timelines: periconception, 1 to 10 weeks of gestation, and 3 to 8 weeks of gestation when critical heart development takes place. Information regarding maternal vaccination status up to six months before periconception was also logged.
Out of the 161,731 mother-infant pairs examined, 3,795 experienced COVID-19 exposure during gestation. The analysis identified 3,200 total infant cases of congenital heart disease (CHD). This broader count included 306 cases of significant CHD (sCHD), defined as at least one major structural cardiac defect identified via a validated algorithm, and 64 cases of critical CHD (CCHD), which required cardiac intervention or resulted in death within 60 days. Researchers also recorded 1,074 ventricular septal defect (VSD) cases and 1,304 atrial septal defect (ASD) cases.
Infections Between 3 and 8 Weeks Increase Heart Defects
Closer analysis revealed clear distinctions based on when the viral infection occurred. Women who tested positive for COVID-19 via polymerase chain reaction between 3 and 8 weeks of gestation faced a heightened risk of having infants with CCHD and ASD. The data also pointed to an elevated risk for VSD among infants born without chromosomal defects during this same developmental window.
Conversely, infections occurring during periconception alone did not increase infant CHD risk. For the 18% of mothers in the cohort who received a COVID-19 vaccine up to six months prior to periconception, statistical analysis showed no difference in congenital heart disease outcomes compared to unexposed groups.
Future Research and Mechanisms of Viral Impact
Dr. Archer and her team emphasize that further investigation is required to map the exact biological patterns and cellular mechanisms through which SARS-CoV-2 infection during the critical window of fetal development alters infant cardiac risk. Researchers also note that additional study is necessary to better understand the role of vaccination.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.